Company / Capital Returned to Shareholders
ANAPTYSBIO, INC Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$68.6M
FY2025
5-year range
$456.0K / $68.6M
FY2021-FY2025
Trend
+14949.6%
vs FY2024
Sector context
#28 of 52
Health Care
What the data says
Capital Returned to Shareholders changed +14950% YoY in FY2025, a notable deviation from the 3-year average annual change of +4917%.
Based on SEC 10-K filings.
$69M in FY2025.
Improved from $50M to $69M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#28 of 52 in Health CareTop 54% of 52This company $68.6M Sector average $1.3B
▼
-94.9% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders increased 14949.6% year-over-year.
- Ranks #28 out of 52 companies in the Health Care sector.
- Lowest capital returned to shareholders in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $68.6M | +14949.6% |
| FY2024 | $456.0K | -99.1% |
| FY2023 | $50.0M | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $0 | - |
| FY2017 | $0 | -100.0% |
| FY2016 | $1.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026